Stock Quote
Novo Nordisk A/S (NOVOb.CO) (Copenhagen Stock Exchange)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View NOVOb on other exchanges
kr.322.50
3:46am EST
-0.08%
kr.322.75
kr.319.25
132,545
kr.323.00
kr.319.00
kr.333.75
kr.234.50
0.28
677,002
No news stories for this company within the last 30 days.
NOVOb.CO
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Scheibye, Sten | Independent Chairman of the Board | 1,000,000 |
| Rebien Soerensen, Lars | President, Chief Executive Officer | 8,700,000 |
| Ando, Goran | Vice Chairman of the Board, Research and Development Facilitator | 600,000 |
Profile
Novo Nordisk A/S is a Denmark-based healthcare company. The Company provides diabetes care and is engaged in haemostasis management, growth hormone therapy and hormone replacement therapy. The Company manufactures and markets pharmaceutical products and services to patients, the medical profession... Full Description
Company Address
Novo Nordisk A/S
Novo Alle
Bagsvaerd 2880
P: +4544.448888
F: +4544.436633
Novo Alle
Bagsvaerd 2880
P: +4544.448888
F: +4544.436633
Analyst Research
| NOVOb.CO | Industry | |
|---|---|---|
| P/E(TTM) | 18.64 | 3.60 |
| P/S(TTM) | 3.85 | 0.57 |
| ROI(TTM) | 28.23 | 1.86 |
| ROE(TTM) | 32.14 | 2.52 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 17.94 |
| Total Revenue | $12,517.00M |
| Net Income | $2,755.00M |
| EPS | $4.58 |
